Focus is obviously on Sofdra approval.
Imagine once this passes the rest of the pipeline will be reinstated, ideally with BTX1801 and BTX1503 being the near term catalysts.
It costs money for phase 3 trials in these markets as we know and we need to utilise capital as much as possible.
Focus is obviously on Sofdra approval.Imagine once this passes...
-
- There are more pages in this discussion • 2,421 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
37.0¢ |
Change
-0.010(2.63%) |
Mkt cap ! $669.7M | |||
| Open | High | Low | Value | Volume |
| 37.5¢ | 38.0¢ | 35.0¢ | $3.419M | 9.346M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 10 | 232238 | 37.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 37.5¢ | 159799 | 10 |
View Market Depth
| Last trade - 15.21pm 15/07/2024 (20 minute delay) ? |
| BOT (ASX) Chart |